The University of Southampton
University of Southampton Institutional Repository

Unexpected role of surface transglutaminase type II in celiac disease

Unexpected role of surface transglutaminase type II in celiac disease
Unexpected role of surface transglutaminase type II in celiac disease
Background & Aims: In celiac disease (CD), transglutaminase type II (TG2) has 2 fundamental roles: (1) as the autoantigen recognized by highly specific autoantibodies and (2) the modifier of pathogenic gliadin T-cell epitopes. It follows that inhibition of TG2 might represent an attractive strategy to curb the toxic action of gliadin. Here we studied the validity of this strategy using the organ culture approach.
Methods: Duodenal biopsy specimens from 30 treated patients with CD, 33 untreated patients with CD, and 24 controls were cultured with or without gliadin peptides p31-43, p?-9, and deamidated p?-9 for 20 minutes, 3 hours, and 24 hours. In 31 patients with CD and 16 controls, TG2 inhibitor R283 or anti-TG CUB 7402 or anti-surface TG2 (6B9) mAbs were used in cultures. T84 cells were also cultured with or without peptides with or without TG inhibitors. Mucosal modifications after culture were assessed by immunofluorescence, in situ detection of TG activity, confocal microscopy, and fluorescence-activated cell sorter analysis.
Results: The enzymatic inhibition of TG2 only controlled gliadin-specific T-cell activation. The binding of surface TG2 contained gliadin-specific T-cell activation and p31-43–induced actin rearrangement, epithelial phosphorylation, and apoptosis, both in organ cultures and T84 cells.
Conclusions: These data indicate a novel and unexpected biological role for surface TG2 in the pathogenesis of CD suggesting a third role for TG2 in CD. These results have a specific impact for celiac disease, with wider implications indicating a novel biologic function of TG2 with possible repercussions in other diseases.
0016-5085
1400-1413
Maiuri, L.
11e256c3-912e-4479-b19d-1f64e4f2fd46
Ciacci, C.
1726213f-9664-4738-8e1a-d064540dbd14
Ricciardelli, I.
c0a412c8-69d3-4146-83d9-aa508bbbe471
Vacca, L.
0130f2fe-933c-47a5-bde3-c0ed1469130c
Raia, V.
d2c9486f-60ec-4132-827a-506f0797d1c0
Rispo, A.
676c75b6-f44d-42bb-bcc5-3e070b1d8323
Griffin, M.
e94dedc4-5b43-4b4d-af0a-412475b92288
Issekutz, T.
25a9c318-bb1e-4084-95bb-d367f0f872af
Quaratino, S.
e111fc36-bc7e-461b-996d-849e97c51e44
Londei, M.
2d82e120-d610-4bb3-9f93-441ee4c7d419
Maiuri, L.
11e256c3-912e-4479-b19d-1f64e4f2fd46
Ciacci, C.
1726213f-9664-4738-8e1a-d064540dbd14
Ricciardelli, I.
c0a412c8-69d3-4146-83d9-aa508bbbe471
Vacca, L.
0130f2fe-933c-47a5-bde3-c0ed1469130c
Raia, V.
d2c9486f-60ec-4132-827a-506f0797d1c0
Rispo, A.
676c75b6-f44d-42bb-bcc5-3e070b1d8323
Griffin, M.
e94dedc4-5b43-4b4d-af0a-412475b92288
Issekutz, T.
25a9c318-bb1e-4084-95bb-d367f0f872af
Quaratino, S.
e111fc36-bc7e-461b-996d-849e97c51e44
Londei, M.
2d82e120-d610-4bb3-9f93-441ee4c7d419

Maiuri, L., Ciacci, C., Ricciardelli, I., Vacca, L., Raia, V., Rispo, A., Griffin, M., Issekutz, T., Quaratino, S. and Londei, M. (2005) Unexpected role of surface transglutaminase type II in celiac disease. Gastroenterology, 129 (5), 1400-1413. (doi:10.1053/j.gastro.2005.07.054).

Record type: Article

Abstract

Background & Aims: In celiac disease (CD), transglutaminase type II (TG2) has 2 fundamental roles: (1) as the autoantigen recognized by highly specific autoantibodies and (2) the modifier of pathogenic gliadin T-cell epitopes. It follows that inhibition of TG2 might represent an attractive strategy to curb the toxic action of gliadin. Here we studied the validity of this strategy using the organ culture approach.
Methods: Duodenal biopsy specimens from 30 treated patients with CD, 33 untreated patients with CD, and 24 controls were cultured with or without gliadin peptides p31-43, p?-9, and deamidated p?-9 for 20 minutes, 3 hours, and 24 hours. In 31 patients with CD and 16 controls, TG2 inhibitor R283 or anti-TG CUB 7402 or anti-surface TG2 (6B9) mAbs were used in cultures. T84 cells were also cultured with or without peptides with or without TG inhibitors. Mucosal modifications after culture were assessed by immunofluorescence, in situ detection of TG activity, confocal microscopy, and fluorescence-activated cell sorter analysis.
Results: The enzymatic inhibition of TG2 only controlled gliadin-specific T-cell activation. The binding of surface TG2 contained gliadin-specific T-cell activation and p31-43–induced actin rearrangement, epithelial phosphorylation, and apoptosis, both in organ cultures and T84 cells.
Conclusions: These data indicate a novel and unexpected biological role for surface TG2 in the pathogenesis of CD suggesting a third role for TG2 in CD. These results have a specific impact for celiac disease, with wider implications indicating a novel biologic function of TG2 with possible repercussions in other diseases.

This record has no associated files available for download.

More information

Published date: 2005

Identifiers

Local EPrints ID: 26458
URI: http://eprints.soton.ac.uk/id/eprint/26458
ISSN: 0016-5085
PURE UUID: 7a5f8612-dda8-4ff6-90ea-3ae04def4174

Catalogue record

Date deposited: 19 Apr 2006
Last modified: 15 Mar 2024 07:11

Export record

Altmetrics

Contributors

Author: L. Maiuri
Author: C. Ciacci
Author: I. Ricciardelli
Author: L. Vacca
Author: V. Raia
Author: A. Rispo
Author: M. Griffin
Author: T. Issekutz
Author: S. Quaratino
Author: M. Londei

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×